Annual CAPEX
$22.29 M
0.00%
31 December 2023
Summary:
Iovance Biotherapeutics annual capital expenditures is currently $22.29 millionIOVA annual CAPEX is now at all-time high.IOVA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$2.29 M
+$1.85 M+417.65%
30 September 2024
Summary:
Iovance Biotherapeutics quarterly capital expenditures is currently $2.29 million, with the most recent change of +$1.85 million (+417.65%) on 30 September 2024. Over the past year, it has dropped by -$1.29 million (-36.04%). IOVA quarterly CAPEX is now -75.97% below its all-time high of $9.52 million, reached on 30 June 2023.IOVA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$10.43 M
-$1.29 M-11.00%
30 September 2024
Summary:
Iovance Biotherapeutics TTM capital expenditures is currently $10.43 million, with the most recent change of -$1.29 million (-11.00%) on 30 September 2024. Over the past year, it has dropped by -$2.67 million (-20.36%). IOVA TTM CAPEX is now -49.85% below its all-time high of $20.80 million, reached on 31 March 2024.IOVA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IOVA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -36.0% | -20.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
IOVA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | -76.0% | +417.6% | -49.9% | +9.6% |
| 5 y | 5 years | at high | at low | -76.0% | +417.6% | -49.9% | +9.6% |
| alltime | all time | at high | at low | -76.0% | +417.6% | -49.9% | +9.6% |
Iovance Biotherapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.29 M(+417.6%) | $10.43 M(-11.0%) |
| June 2024 | - | $442.00 K(-89.4%) | $11.72 M(-43.7%) |
| Mar 2024 | - | $4.17 M(+18.2%) | $20.80 M(+25.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $22.29 M | $3.53 M(-1.3%) | $16.63 M(+26.9%) |
| Sept 2023 | - | $3.58 M(-62.4%) | $13.10 M(+37.6%) |
| June 2023 | - | $9.52 M | $9.52 M |
FAQ
- What is Iovance Biotherapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics quarterly CAPEX year-on-year change?
- What is Iovance Biotherapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Iovance Biotherapeutics?
- What is Iovance Biotherapeutics TTM CAPEX year-on-year change?
What is Iovance Biotherapeutics annual capital expenditures?
The current annual CAPEX of IOVA is $22.29 M
What is the all time high annual CAPEX for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high annual capital expenditures is $22.29 M
What is Iovance Biotherapeutics quarterly capital expenditures?
The current quarterly CAPEX of IOVA is $2.29 M
What is the all time high quarterly CAPEX for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high quarterly capital expenditures is $9.52 M
What is Iovance Biotherapeutics quarterly CAPEX year-on-year change?
Over the past year, IOVA quarterly capital expenditures has changed by -$1.29 M (-36.04%)
What is Iovance Biotherapeutics TTM capital expenditures?
The current TTM CAPEX of IOVA is $10.43 M
What is the all time high TTM CAPEX for Iovance Biotherapeutics?
Iovance Biotherapeutics all-time high TTM capital expenditures is $20.80 M
What is Iovance Biotherapeutics TTM CAPEX year-on-year change?
Over the past year, IOVA TTM capital expenditures has changed by -$2.67 M (-20.36%)